| POLX |
Polarean Imaging
|
AIM |
|
– |
0.08 |
-3.20% |
| TLY |
Totally
|
AIM |
|
– |
0.24 |
-1.90% |
| TRLS |
Trellus Health
|
AIM |
|
– |
0.12 |
7.30% |
| GUN |
Gunsynd
|
AIM |
|
£1.33M |
0.08 |
9.50% |
| VAL |
ValiRx
|
AIM |
|
£1.98M |
0.16 |
-2.20% |
| FUM |
Futura Medical
|
AIM |
|
£2.09M |
0.37 |
14.60% |
| PYC |
Physiomics
|
AIM |
|
£2.11M |
0.46 |
-3.80% |
| BELL |
Belluscura
|
AIM |
|
£3.01M |
0.75 |
-1.10% |
| OBD |
Oxford BioDynamics
|
AIM |
|
£4.51M |
0.11 |
-4.00% |
| MHC |
MyHealthChecked
|
AIM |
|
£4.55M |
8.75 |
5.30% |
| SUN |
Surgical Innovations Group
|
AIM |
|
£4.66M |
0.50 |
-2.30% |
| VRCI |
Verici Dx
|
AIM |
|
£5.03M |
0.22 |
-4.80% |
| TRX |
Tissue Regenix Group
|
AIM |
|
£5.16M |
7.25 |
-1.50% |
| OPTI |
OptiBiotix Health
|
AIM |
|
£5.94M |
5.75 |
-3.30% |
| PRM |
Proteome Sciences
|
AIM |
|
£6.31M |
2.10 |
8.00% |
| GENI |
Genincode
|
AIM |
|
£6.78M |
0.85 |
1.40% |
| AGL |
Angle
|
AIM |
|
£7.72M |
2.40 |
-0.70% |
| CEL |
Celadon Pharmaceuticals
|
AIM |
|
£9.23M |
13.40 |
% |
| FAB |
Fusion Antibodies
|
AIM |
|
£13.13M |
10.50 |
25.90% |
| RUA |
RUA Life Sciences
|
AIM |
|
£14.89M |
24.00 |
-6.90% |
| COG |
Cambridge Cognition Holdings
|
AIM |
|
£15.36M |
33.00 |
-0.40% |
| IHC |
Inspiration Healthcare Group
|
AIM |
|
£16.59M |
18.00 |
0.60% |
| IXI |
Ixico
|
AIM |
|
£17.44M |
8.00 |
-1.50% |
| GDR |
Genedrive
|
AIM |
|
£18.46M |
1.15 |
-1.60% |
| EDEN |
Eden Research
|
AIM |
|
£20.49M |
2.55 |
-2.40% |
| AREC |
Arecor Therapeutics
|
AIM |
|
£23.03M |
60.00 |
-1.30% |
| IMM |
ImmuPharma
|
AIM |
|
£24.96M |
4.45 |
-3.00% |
| NCYT |
Novacyt SA
|
AIM |
|
£26.52M |
37.05 |
4.20% |
| SBTX |
SkinBioTherapeutics
|
AIM |
|
£29.8M |
11.25 |
-14.90% |
| SAR |
Sareum Holdings
|
AIM |
|
£31.87M |
23.00 |
-5.60% |
| STX |
Shield Therapeutics
|
AIM |
|
£39.59M |
4.00 |
-7.90% |
| OHGR |
One Health Group
|
AIM |
2.17 |
£39.77M |
288.00 |
% |
| ABDX |
Abingdon Health
|
AIM |
|
£45.68M |
10.50 |
2.60% |
| HVO |
Hvivo
|
AIM |
2.87 |
£47.4M |
6.95 |
-5.10% |
| POLB |
Poolbeg Pharma
|
AIM |
|
£54.97M |
8.30 |
-2.10% |
| KMK |
Kromek Group
|
AIM |
|
£55.03M |
7.92 |
8.70% |
| CREO |
Creo Medical Group
|
AIM |
|
£59.51M |
12.88 |
-0.80% |
| ANIC |
Agronomics
|
AIM |
|
£62.84M |
5.60 |
-0.60% |
| OBI |
Ondine Biomedical Inc
|
AIM |
|
£67.54M |
13.00 |
2.60% |
| EAH |
Eco Animal Health Group
|
AIM |
|
£67.76M |
100.00 |
-4.30% |
| BVXP |
Bioventix
|
AIM |
9.93 |
£78.9M |
1,500.00 |
-2.20% |
| 4BB |
4basebio
|
AIM |
|
£81.58M |
525.00 |
-0.40% |
| SDI |
SDI Group
|
AIM |
|
£93.05M |
89.00 |
-1.50% |
| FARN |
Faron Pharmaceuticals OY
|
AIM |
|
£94.23M |
41.50 |
1.10% |
| SPEC |
Inspecs Group
|
AIM |
|
£98.62M |
97.00 |
-0.30% |
| ANP |
Anpario
|
AIM |
2.36 |
£107.22M |
530.00 |
-0.90% |
| EKF |
EKF Diagnostics Holdings
|
AIM |
|
£110.42M |
25.75 |
1.00% |
| SCLP |
Scancell Holdings
|
AIM |
|
£120.01M |
9.74 |
-1.10% |
| DXRX |
Diaceutics
|
AIM |
|
£122.35M |
145.00 |
-0.50% |
| BMK |
Benchmark Holdings
|
AIM |
|
£135.69M |
22.05 |
1.50% |
| MXCT |
Maxcyte Inc
|
AIM |
|
£161.75M |
147.69 |
-1.20% |
| BTG |
BTG
|
AIM |
4.26 |
£174.16M |
108.50 |
-0.10% |
| TSTL |
Tristel
|
AIM |
3.34 |
£203.94M |
415.00 |
1.60% |
| ANCR |
Animalcare Group
|
AIM |
0.66 |
£231.3M |
335.00 |
-2.60% |
| NIOX |
Niox Group
|
AIM |
2.53 |
£257.47M |
62.40 |
% |
| PRTC |
Puretech Health
|
FTSE Small Cap |
|
£290.32M |
116.00 |
-2.36% |
| AVCT |
Avacta Group
|
AIM |
|
£318.51M |
68.00 |
-7.00% |
| AGY |
Allergy Therapeutics
|
AIM |
|
£332.46M |
5.00 |
-2.50% |
| AMS |
Advanced Medical Solutions Group
|
AIM |
1.02 |
£608.12M |
281.00 |
3.10% |
| OXB |
Oxford BioMedica
|
FTSE Small Cap |
|
£685.11M |
574.00 |
1.41% |
| SPI |
Spire Healthcare Group
|
FTSE 250 |
0.65 |
£926.35M |
232.50 |
1.09% |
| UPR |
Uniphar
|
AIM |
0.48 |
£932.68M |
365.00 |
0.90% |
| GNS |
Genus
|
FTSE 250 |
1.45 |
£1.47B |
2,260.00 |
2.54% |
| HCM |
Hutchmed China
|
AIM |
|
£1.5B |
178.00 |
4.80% |
| INDV |
Indivior
|
FTSE 250 |
|
£1.54B |
1,238.00 |
-3.10% |
| HIK |
Hikma Pharmaceuticals
|
FTSE 100 |
3.95 |
£3.32B |
1,571.00 |
-0.63% |
| CTEC |
ConvaTec Group
|
FTSE 100 |
2.35 |
£4.48B |
223.80 |
-2.44% |
| SN. |
Smith & Nephew
|
FTSE 100 |
2.44 |
£9.42B |
1,108.50 |
-1.20% |
| HLN |
Haleon
|
FTSE 100 |
2.04 |
£31.51B |
365.70 |
2.24% |
| GSK |
GSK
|
FTSE 100 |
3.76 |
£77.45B |
1,915.50 |
0.05% |
| AZN |
AstraZeneca
|
FTSE 100 |
2.04 |
£182.09B |
12,036.00 |
2.52% |